Treatment of Inflammatory and Paraproteinemic Neuropathies

E-ISSN： 1875-5917|4|2|141-148

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.2, 2004-06, pp. : 141-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies

Current Neuropharmacology, Vol. 7, Iss. 4, 2009-12 ,pp. : 337-342

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 1, 2010-03 ,pp. : 47-64

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

Pimecrolimus for the treatment of inflammatory skin disease

By Wolff Klaus Stuetz Anton

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 643-655

Informa Healthcare

Access to resources Recommend Favorite